Evan Cheng
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Evan Cheng has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
- Austin Hartman
New York Genome Center
1 shared publication Drew Adler
Center for Neural Science, New York University, New York, USA
1 shared publication- Eric Klann
New York University
1 shared publication - Longda Jiang
New York Genome Center, New York, USA
1 shared publication - Nathan Nakatsuka
New York Genome Center
1 shared publication - Rahul Satija
New York Genome Center
1 shared publication
Latest Publications
- Open Access
- 12 August 2025
- Published by Springer Nature in Nature Communications
- Vol. 16 (1) , 1-20
Improving reproducibility of differentially expressed genes in single-cell transcriptomic studies of neurodegenerative diseases through meta-analysis
False positive claims of differentially expressed genes (DEGs) in scRNA-seq studies are of substantial concern. We found that DEGs from individual Parkinson’s (PD), Huntington’s (HD), and COVID-19 datasets had moderate predictive power for case-control status of other datasets, but DEGs from Alzheimer’s (AD) and Schizophrenia (SCZ) datasets had poor predictive power. We developed a non-parametric meta-analysis method, SumRank, based on reproducibility of relative differential expression ranks across datasets, and found DEGs with improved predictive power. Specificity and sensitivity of these genes were substantially higher than those discovered by dataset merging and inverse variance weighted p-value aggregation methods. Up-regulated DEGs implicated chaperone-mediated protein processing in PD glia and lipid transport in AD and PD microglia, while down-regulated DEGs were in glutamatergic processes in AD astrocytes and excitatory neurons and synaptic functioning in HD FOXP2 neurons. Lastly, we evaluate factors influencing reproducibility of individual studies as a prospective guide for experimental design.
- 12 August 2025
- Published by Springer Nature in Nature Communications
- Vol. 16 (1) , 1-20
Open AccessImproving reproducibility of differentially expressed genes in single-cell transcriptomic studies of neurodegenerative diseases through meta-analysis
False positive claims of differentially expressed genes (DEGs) in scRNA-seq studies are of substantial concern. We found that DEGs from individual Parkinson’s (PD), Huntington’s (HD), and COVID-19 datasets had moderate predictive power for case-control status of other datasets, but DEGs from Alzheimer’s (AD) and Schizophrenia (SCZ) datasets had poor predictive power. We developed a non-parametric meta-analysis method, SumRank, based on reproducibility of relative differential expression ranks across datasets, and found DEGs with improved predictive power. Specificity and sensitivity of these genes were substantially higher than those discovered by dataset merging and inverse variance weighted p-value aggregation methods. Up-regulated DEGs implicated chaperone-mediated protein processing in PD glia and lipid transport in AD and PD microglia, while down-regulated DEGs were in glutamatergic processes in AD astrocytes and excitatory neurons and synaptic functioning in HD FOXP2 neurons. Lastly, we evaluate factors influencing reproducibility of individual studies as a prospective guide for experimental design.